<!DOCTYPE html> <html lang="en"> <head> <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"> <meta charset="utf-8"> <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <title>Antiprogestins for breast cancer prevention | Chiara Herzog</title> <meta name="author" content="Chiara Herzog"> <meta name="description" content="Chiara Herzog's website. "> <meta name="keywords" content="chiara herzog, methylation, biomarkers of aging, prevention research, cancer detection"> <link href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.1/dist/css/bootstrap.min.css" rel="stylesheet" integrity="sha256-DF7Zhf293AJxJNTmh5zhoYYIMs2oXitRfBjY+9L//AY=" crossorigin="anonymous"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/css/mdb.min.css" integrity="sha256-jpjYvU3G3N6nrrBwXJoVEYI/0zw8htfFnhT9ljN3JJw=" crossorigin="anonymous"> <link defer rel="stylesheet" href="https://unpkg.com/bootstrap-table@1.21.4/dist/bootstrap-table.min.css"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.4.0/css/all.min.css" integrity="sha256-HtsXJanqjKTc8vVQjO4YMhiqFoXkfBsjBWcX91T1jr8=" crossorigin="anonymous"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/academicons@1.9.1/css/academicons.min.css" integrity="sha256-i1+4qU2G2860dGGIOJscdC30s9beBXjFfzjWLjBRsBg=" crossorigin="anonymous"> <link rel="stylesheet" type="text/css" href="https://fonts.googleapis.com/css?family=Roboto:300,400,500,700|Roboto+Slab:100,300,400,500,700|Material+Icons"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/jwarby/jekyll-pygments-themes@master/github.css" media="" id="highlight_theme_light"> <link rel="shortcut icon" href="data:image/svg+xml,&lt;svg%20xmlns=%22http://www.w3.org/2000/svg%22%20viewBox=%220%200%20100%20100%22&gt;&lt;text%20y=%22.9em%22%20font-size=%2290%22&gt;%F0%9F%8C%99&lt;/text&gt;&lt;/svg&gt;"> <link rel="stylesheet" href="/assets/css/main.css?d41d8cd98f00b204e9800998ecf8427e"> <link rel="canonical" href="https://chiaraherzog.github.io/blog/2022/mifepristone/"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/jwarby/jekyll-pygments-themes@master/native.css" media="none" id="highlight_theme_dark"> <script src="/assets/js/theme.js?96d6b3e1c3604aca8b6134c7afdd5db6"></script> <script src="/assets/js/dark_mode.js?9b17307bb950ffa2e34be0227f53558f"></script> </head> <body class="fixed-top-nav "> <header> <nav id="navbar" class="navbar navbar-light navbar-expand-sm fixed-top"> <div class="container"> <a class="navbar-brand title font-weight-lighter" href="/"><span class="font-weight-bold">ChiaraÂ </span>Herzog</a> <button class="navbar-toggler collapsed ml-auto" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation"> <span class="sr-only">Toggle navigation</span> <span class="icon-bar top-bar"></span> <span class="icon-bar middle-bar"></span> <span class="icon-bar bottom-bar"></span> </button> <div class="collapse navbar-collapse text-right" id="navbarNav"> <ul class="navbar-nav ml-auto flex-nowrap"> <li class="nav-item "> <a class="nav-link" href="/">about</a> </li> <li class="nav-item "> <a class="nav-link" href="/cv/">cv</a> </li> <li class="nav-item "> <a class="nav-link" href="/projects/">projects</a> </li> <li class="nav-item "> <a class="nav-link" href="/publications/">publications</a> </li> <li class="nav-item "> <a class="nav-link" href="/tools/">tools</a> </li> <li class="nav-item "> <a class="nav-link" href="/teaching/">teaching</a> </li> <li class="nav-item "> <a class="nav-link" href="/outreach/">media &amp; outreach</a> </li> <li class="nav-item"> <a class="nav-link" href="mailto:%63%68%69%61%72%61.%68%65%72%7A%6F%67@%75%69%62%6B.%61%63.%61%74" title="email"> <i class="fas fa-envelope"></i> </a> </li> <li class="toggle-container"> <button id="light-toggle" title="Change theme"> <i class="fas fa-moon"></i> <i class="fas fa-sun"></i> </button> </li> </ul> </div> </div> </nav> <progress id="progress" value="0"> <div class="progress-container"> <span class="progress-bar"></span> </div> </progress> </header> <div class="container mt-5"> <div class="post"> <header class="post-header"> <h1 class="post-title">Antiprogestins for breast cancer prevention</h1> <p class="post-meta">June 15, 2022</p> <p class="post-tags"> <a href="/blog/2022"> <i class="fas fa-calendar fa-sm"></i> 2022 </a> Â  Â· Â  <a href="/blog/tag/breast-cancer"> <i class="fas fa-hashtag fa-sm"></i> breast-cancer</a> Â  <a href="/blog/tag/risk-prediction"> <i class="fas fa-hashtag fa-sm"></i> risk-prediction</a> Â  <a href="/blog/tag/prevention"> <i class="fas fa-hashtag fa-sm"></i> prevention</a> Â  Â  Â· Â  <a href="/blog/category/papers"> <i class="fas fa-tag fa-sm"></i> papers</a> Â  </p> </header> <article class="post-content"> <div id="markdown-content"> <p>Our new paper looking into antiprogestins for prevention of breast cancer alongside epigenetic monitoring appeard in Genome Medicine today.</p> </div> </article> <h2>References</h2> <div class="publications"> <h2 class="bibliography">2022</h2> <ol class="bibliography"><li> <div class="row"> <div class="col-sm-2 preview"> <figure> <picture> <source class="responsive-img-srcset" media="(max-width: 480px)" srcset="/assets/img/publication_preview/mife-480.webp"></source> <source class="responsive-img-srcset" media="(max-width: 800px)" srcset="/assets/img/publication_preview/mife-800.webp"></source> <source class="responsive-img-srcset" media="(max-width: 1400px)" srcset="/assets/img/publication_preview/mife-1400.webp"></source> <img src="/assets/img/publication_preview/mife.png" class="preview z-depth-1 rounded" width="auto" height="auto" alt="mife.png" data-zoomable onerror="this.onerror=null; $('.responsive-img-srcset').remove();"> </picture> </figure> </div> <div id="mife" class="col-sm-8"> <div class="title">Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women</div> <div class="author"> Thomas E. Bartlett,Â Iona Evans,Â Allison Jones, and <span class="more-authors" title="click to view 20 more authors" onclick=" var element=$(this); element.attr('title', ''); var more_authors_text=element.text() == '20 more authors' ? 'James E. Barrett, Shaun Haran, Daniel Reisel, Kiriaki Papaikonomou, Louise Jones, Chiara Herzog, Nora Pashayan, Bruno M. SimÃµes, Robert B. Clarke, D. Gareth Evans, Talayeh S. Ghezelayagh, Sakthivignesh Ponandai-Srinivasan, Nageswara R. Boggavarapu, Parameswaran G. Lalitkumar, Sacha J. Howell, Rosa Ana Risques, Angelique FlÃ¶ter RÃ¥destad, Louis Dubeau, Kristina Gemzell-Danielsson, Martin Widschwendter' : '20 more authors'; var cursorPosition=0; var textAdder=setInterval(function(){ element.text(more_authors_text.substring(0, cursorPosition + 1)); if (++cursorPosition == more_authors_text.length){ clearInterval(textAdder); } }, '0.01'); ">20 more authors</span> </div> <div class="periodical"> <em>Genome Medicine</em>, 2022 </div> <div class="periodical"> </div> <div class="links"> <a class="abstract btn btn-sm z-depth-0" role="button">Abs</a> <a href="https://doi.org/10.1186/s13073-022-01063-5" class="btn btn-sm z-depth-0" role="button" rel="external nofollow noopener" target="_blank">HTML</a> </div> <div class="badges"> <span class="altmetric-embed" data-hide-no-mentions="true" data-hide-less-than="15" data-badge-type="2" data-badge-popover="right" data-doi="10.1186/s13073-022-01063-5"></span> <span class="__dimensions_badge_embed__" data-doi="10.1186/s13073-022-01063-5" data-hide-zero-citations="true" data-style="small_rectangle" data-legend="hover-right" style="margin-bottom: 3px;"></span> </div> <div class="abstract hidden"> <p>Breast cancer is a leading cause of death in premenopausal women. Progesterone drives expansion of luminal progenitor cells, leading to the development of poor-prognostic breast cancers. However, it is not known if antagonising progesterone can prevent breast cancers in humans. We suggest that targeting progesterone signalling could be a means of reducing features which are known to promote breast cancer formation. In healthy premenopausal women with and without a BRCA mutation we studied (i) estrogen and progesterone levels in saliva over an entire menstrual cycle (n = 20); (ii) cancer-free normal breast-tissue from a control population who had no family or personal history of breast cancer and equivalently from BRCA1/2 mutation carriers (n = 28); triple negative breast cancer (TNBC) biopsies and healthy breast tissue taken from sites surrounding the TNBC in the same individuals (n = 14); and biopsies of ER+ve/PR+ve stage T1â€“T2 cancers and healthy breast tissue taken from sites surrounding the cancer in the same individuals (n = 31); and (iii) DNA methylation and DNA mutations in normal breast tissue (before and after treatment) from clinical trials that assessed the potential preventative effects of vitamins and antiprogestins (mifepristone and ulipristal acetate; n = 44). Daily levels of progesterone were higher throughout the menstrual cycle of BRCA1/2 mutation carriers, raising the prospect of targeting progesterone signalling as a means of cancer risk reduction in this population. Furthermore, breast field cancerization DNA methylation signatures reflective of (i) the mitotic age of normal breast epithelium and (ii) the proportion of luminal progenitor cells were increased in breast cancers, indicating that luminal progenitor cells with elevated replicative age are more prone to malignant transformation. The progesterone receptor antagonist mifepristone reduced both the mitotic age and the proportion of luminal progenitor cells in normal breast tissue of all control women and in 64% of BRCA1/2 mutation carriers. These findings were validated by an alternate progesterone receptor antagonist, ulipristal acetate, which yielded similar results. Importantly, mifepristone reduced both the TP53 mutation frequency as well as the number of TP53 mutations in mitotic-age-responders. These data support the potential usage of antiprogestins for primary prevention of poor-prognostic breast cancers. Clinical trial 1 Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control â€“ a randomized controlled trial, clinicaltrialsregister.eu, 2009-009014-40; registered on 20 July 2009. Clinical trial 2 The effect of a progesterone receptor modulator on breast tissue in women with BRCA1 and 2 mutations, clinicaltrials.gov, NCT01898312; registered on 07 May 2013. Clinical trial 3 A pilot prevention study of the effects of the anti- progestin Ulipristal Acetate (UA) on surrogate markers of breast cancer risk, clinicaltrialsregister.eu, 2015-001587-19; registered on 15 July 2015.</p> </div> </div> </div> </li></ol> </div> <br> <hr> <br> <ul class="list-disc pl-8"></ul> <h2 class="text-3xl font-semibold mb-4 mt-12">Other news</h2> <p class="mb-2"></p> <li class="my-2"> <a class="text-pink-700 underline font-semibold hover:text-pink-800" href="/blog/2024/ysa/">I was awarded the AGO Austria Young Scientist Award ðŸŒŸ</a> </li> <li class="my-2"> <a class="text-pink-700 underline font-semibold hover:text-pink-800" href="/blog/2024/milan/">Panelist at Milan Longevity Summit</a> </li> <li class="my-2"> <a class="text-pink-700 underline font-semibold hover:text-pink-800" href="/blog/2024/canres/">New paper on impact of tobacco and vaping on epigenome</a> </li> <li class="my-2"> <a class="text-pink-700 underline font-semibold hover:text-pink-800" href="/blog/2024/natmed/">Validation of Biomarkers of Aging in Nature Medicine</a> </li> <li class="my-2"> <a class="text-pink-700 underline font-semibold hover:text-pink-800" href="/blog/2024/stard/">New R package for STARD diagrams</a> </li> </div> </div> <footer class="fixed-bottom"> <div class="container mt-0"> Â© Copyright 2024 Chiara Herzog. Last updated: May 15, 2024. </div> </footer> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.0/dist/jquery.min.js" integrity="sha256-/xUj+3OJU5yExlq6GSYGSHk7tPXikynS7ogEvDej/m4=" crossorigin="anonymous"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.1/dist/js/bootstrap.bundle.min.js" integrity="sha256-fgLAgv7fyCGopR/gBNq2iW3ZKIdqIcyshnUULC4vex8=" crossorigin="anonymous"></script> <script src="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/js/mdb.min.js" integrity="sha256-NdbiivsvWt7VYCt6hYNT3h/th9vSTL4EDWeGs5SN3DA=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/masonry-layout@4.2.2/dist/masonry.pkgd.min.js" integrity="sha256-Nn1q/fx0H7SNLZMQ5Hw5JLaTRZp0yILA/FRexe19VdI=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/imagesloaded@4/imagesloaded.pkgd.min.js"></script> <script defer src="/assets/js/masonry.js" type="text/javascript"></script> <script defer src="https://cdn.jsdelivr.net/npm/medium-zoom@1.0.8/dist/medium-zoom.min.js" integrity="sha256-7PhEpEWEW0XXQ0k6kQrPKwuoIomz8R8IYyuU1Qew4P8=" crossorigin="anonymous"></script> <script defer src="/assets/js/zoom.js"></script> <script defer src="https://unpkg.com/bootstrap-table@1.21.4/dist/bootstrap-table.min.js"></script> <script src="/assets/js/no_defer.js?d633890033921b33e0ceb13d22340a9c"></script> <script defer src="/assets/js/common.js?acdb9690d7641b2f8d40529018c71a01"></script> <script defer src="/assets/js/copy_code.js?c9d9dd48933de3831b3ee5ec9c209cac" type="text/javascript"></script> <script async src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script async src="https://badge.dimensions.ai/badge.js"></script> <script type="text/javascript">window.MathJax={tex:{tags:"ams"}};</script> <script defer type="text/javascript" id="MathJax-script" src="https://cdn.jsdelivr.net/npm/mathjax@3.2.0/es5/tex-mml-chtml.js"></script> <script defer src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script> <script async src="https://www.googletagmanager.com/gtag/js?id=G-6ZLF3RJPVS"></script> <script>function gtag(){window.dataLayer.push(arguments)}window.dataLayer=window.dataLayer||[],gtag("js",new Date),gtag("config","G-6ZLF3RJPVS");</script> <script type="text/javascript">function progressBarSetup(){"max"in document.createElement("progress")?(initializeProgressElement(),$(document).on("scroll",function(){progressBar.attr({value:getCurrentScrollPosition()})}),$(window).on("resize",initializeProgressElement)):(resizeProgressBar(),$(document).on("scroll",resizeProgressBar),$(window).on("resize",resizeProgressBar))}function getCurrentScrollPosition(){return $(window).scrollTop()}function initializeProgressElement(){let e=$("#navbar").outerHeight(!0);$("body").css({"padding-top":e}),$("progress-container").css({"padding-top":e}),progressBar.css({top:e}),progressBar.attr({max:getDistanceToScroll(),value:getCurrentScrollPosition()})}function getDistanceToScroll(){return $(document).height()-$(window).height()}function resizeProgressBar(){progressBar.css({width:getWidthPercentage()+"%"})}function getWidthPercentage(){return getCurrentScrollPosition()/getDistanceToScroll()*100}const progressBar=$("#progress");window.onload=function(){setTimeout(progressBarSetup,50)};</script> </body> </html>